spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Symposium on Digitalization and Big Data in Biotech and Pharma

6 June 2018
ETH Zurich, Institute for Chemical and Bioengineering, Vladimir-Prelog-Weg 1

The Symposium on Digitalization and Big Data in Biotech & Pharma will bring together experts and key stakeholders from industry and academia to discuss and current digital innovations and technological trends in the pharmaceutical sector. The presentations by leading industry experts and technology pioneers are complemented by interactive round table discussions, a netwroking lunch, as well as poster and product solution exhibition. The event is organized by the group of Prof. Morbidelli from the Institute of Chemical and Bioengineering at ETH Zurich, Switzerland, and takes place at the Hönggerberg campus of ETH Zurich.

Aim

The symposium brings together key stakeholders and experts in the interdisciplinary field of technology digitalization in the biotechnological and pharmaceutical sectors. All presentations will be based on industrial case studies. Several characteristic perspectives will addressed such as digital needs in R&D and manufacturing, data storage and cloud solutions, centralization and standardization, automated solutions, added value and knowledge generation, on-site integration and transfer as well as regulatory aspects. The symposium aims to outline the key conceptual and implementation challenges, and to highlight the potential of the tools and approaches, which have already been developed and installed. Given the high levels and diversity of the speakers a list of central business and technology drivers will be worked out, which will be later on available as a white paper.

Key Topics

· Role of big data in the pharmaceutical and healthcare business model

· Technological possibilities and limitations for pharmaceutical process digitalization

· Potential of quantitative tools and models

· Available technology, expertise and solutions

· Regulatory agency perspective

· Successful industrial implementations and outlook

Further information and registration

Please visit https://www.datahow.ch/events or contact bigdata@chem.ethz.ch

 
Print this page
Send to a friend
   
spacer
Industry Events

BIO-Europe® 2019 - 25th Annual International Partnering Conference

11-13 November 2019, Hamburg, Germany

The 25th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Learn more.
More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>


News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement